Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(43%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_2
4
57%
Ph phase_1
1
14%
Ph early_phase_1
1
14%

Phase Distribution

2

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
4(57.1%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 24 (57.1%)
N/A1 (14.3%)

Trials by Status

completed343%
recruiting343%
withdrawn114%

Recent Activity

3 active trials
Showing 5 of 7
recruitingphase_2

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

NCT06261814
recruitingphase_2

Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation

NCT05641935
recruitingphase_1

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

NCT06171607
completedphase_2

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

NCT03907657
completedphase_2

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

NCT04021238
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06261814Phase 2

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Recruiting
NCT05641935Phase 2

Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation

Recruiting
NCT06171607Phase 1

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

Recruiting
NCT03907657Phase 2

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

Completed
NCT04021238Phase 2

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

Completed
NCT03407001Early Phase 1

Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis

Completed
NCT03300401Not Applicable

Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization

Withdrawn

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7